<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE589CCE-4366-4CEE-883A-CC75CF6E58D8"><gtr:id>CE589CCE-4366-4CEE-883A-CC75CF6E58D8</gtr:id><gtr:name>Cincinnati Children's Hospital Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8D48FC12-E560-4B37-9CF3-48B80B7FF457"><gtr:id>8D48FC12-E560-4B37-9CF3-48B80B7FF457</gtr:id><gtr:name>Institute of Genetics, Molecular and Cellular Biology (IGBMC)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE589CCE-4366-4CEE-883A-CC75CF6E58D8"><gtr:id>CE589CCE-4366-4CEE-883A-CC75CF6E58D8</gtr:id><gtr:name>Cincinnati Children's Hospital Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8D48FC12-E560-4B37-9CF3-48B80B7FF457"><gtr:id>8D48FC12-E560-4B37-9CF3-48B80B7FF457</gtr:id><gtr:name>Institute of Genetics, Molecular and Cellular Biology (IGBMC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B69DA325-98C3-4795-A3D2-8194CBAA2208"><gtr:id>B69DA325-98C3-4795-A3D2-8194CBAA2208</gtr:id><gtr:firstName>Siew-Lan</gtr:firstName><gtr:surname>Ang</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117570533"><gtr:id>CB8075A7-1AD7-463A-9341-F0C1CED4CB6E</gtr:id><gtr:title>Molecular mechanisms of regionalisation and cell type specification in the vertebrate brain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117570533</gtr:grantReference><gtr:abstractText>How neuronal progenitor cells acquire distinct cell fates in the vertebrate brain is a fundamental problem critical for proper functioning for the brain. Our main interest is to elucidate the molecular and cellular mechanisms specifying the development of distinct neuronal populations in the forebrain and the midbrain.||Our main strategy is to identify transcription factors and signalling pathways that are in the forebrain and midbrain and to analyse their function by different approaches. We have identified several transcription factors and signalling molecules that are required for the development of ventral neuronal subtypes of the midbrain, including dopaminergic neurons. Current projects focus on understanding the molecular and cellular mechanisms regulated by these molecules that specify distinct neuronal populations in the ventral forebrain and midbrain. Our findings may have applications in stem cell therapy for certain neurodegenerative disorders.</gtr:abstractText><gtr:technicalSummary>We are studying the molecular and cellular mechanisms that regulate the proper formation and position of different neuronal cell types in the mouse forebrain and midbrain. Previous work has focused primarily on studying mechanisms of cell-cell communication between ectoderm and underlying tissues that regulate these processes. These studies have led to the discovery of the anterior visceral endoderm, and a genetic network of molecules that regulate the formation of the forebrain and the midbrain. This works uses primarily mouse embryos and applies techniques including classical embryology, developmental genetics, transgenesis, microscopy, and cell and molecular biology. More recently, our main focus is to elucidate the molecular pathways that specify the formation of distinct neuronal populations in the forebrain and midbrain. In these tissues, we focus on neuroendocrine lineages of the hypothalamus and dopaminergic neurons of the midbrain. We would like to determine the intrinsic and extrinsic factors that govern neuronal progenitor cells to differentiate into these cell types. To do this, we will perform loss of function and gain of function studies of candidate regulatory molecules in mice. In addition, lineage analysis will be carried out to identify the progenitors of these different neuronal subtypes using the Cre-loxP recombinase system. For loss of function experiments in mice, we are using the standard gene targeting approach in embryonic stem cells. We have generated mutations in transcription factors, secreted and transmembrane proteins and intracellular transducers of signalling pathways. The roles of these molecules in neuronal specification of the forebrain and midbrain will be analysed by molecular markers, explant and cellular assays. Complementary gain of function approaches involving gene transfer and culture of mouse embryos will also be performed to study epistatic relationships among genes involved in the same development processes. In addition, lineage-tracing experiments will be carried out to study the cellular behaviour and fate of mutant and wild type cells. We will also determine whether the RNA interference approach can be used in mouse embryos to study the function of genes in a high throughput manner. Previously, we have demonstrated that RNA interference is effective to knockdown the activity of two genes, Otx2 and Foxa2, in early post implantation mouse embryos. We will introduce double stranded RNAs (dsRNAs) specific for novel genes into mouse embryos and then examine the ability of these dsRNAs to knock-down specific gene activities. This approach will be used to determine functions of candidate genes involved in neural tube development.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-11-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>6281609</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Genetics and Molecular and Cellular Biology (IGBMC)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Cell Biology and Development</gtr:department><gtr:description>Role of Ngn3 in the development of ventral hypothalamic neurons</gtr:description><gtr:id>B8BA29A3-E7C8-4D87-BABE-514E9B6A01E1</gtr:id><gtr:impact>PMID: 21074524, 21074524</gtr:impact><gtr:outcomeId>V87QSNB7aub-1</gtr:outcomeId><gtr:partnerContribution>Provision of Ngn3 mutant mice</gtr:partnerContribution><gtr:piContribution>We analyzed the development of arcuate neurons in the hypothalamus in Ngn3 mutant embryos</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cincinnati Children's Hospital Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Pulmonary Biology</gtr:department><gtr:description>Analyses of Foxa1 and Foxa2 function in the mouse ventral midbrain</gtr:description><gtr:id>8579BB4E-8D2C-4D7E-9535-FFCBCEC55650</gtr:id><gtr:impact>PMID:
 21093585</gtr:impact><gtr:outcomeId>32B2087B71F-1</gtr:outcomeId><gtr:partnerContribution>Provision of Foxa1 and Foxa2 antibodies</gtr:partnerContribution><gtr:piContribution>We generated all the data and wrote the paper</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Biochemistry and Molecular Biology</gtr:department><gtr:description>Analysis of the function of Lmx1a and Lmx1b in the ventral midbrain</gtr:description><gtr:id>2E195D78-A8C9-44B1-A079-AC0F53C2AE4D</gtr:id><gtr:impact>PMID:
 21880902</gtr:impact><gtr:outcomeId>49A3473E382-1</gtr:outcomeId><gtr:partnerContribution>Provision of a mouse strain</gtr:partnerContribution><gtr:piContribution>We generated all the data published in the paper below.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Grant site visit</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>32A9B71E-03F7-454C-A2CA-2155D3869180</gtr:id><gtr:impact>Reported on research activities funded by two different grants from the Parkinson Disease Society UK. The attendees included research officers and lay members of the society.

not applicable</gtr:impact><gtr:outcomeId>FC65ECECDE2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>152000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant-2005</gtr:description><gtr:end>2008-03-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>2F7C2733-33A0-4E25-ABED-1A18BF9D74BF</gtr:id><gtr:outcomeId>5461ebc054c4b2.05248921</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2005-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>177020</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant-2008</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>E53A3132-A363-4F49-8FB9-E868831424D8</gtr:id><gtr:outcomeId>0370EAAD4980</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>189017</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant-2009</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>E805BB1B-41E1-43D4-8042-E63F11FBCF9F</gtr:id><gtr:outcomeId>13050EBFA230</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>50D9E25A-E702-447C-B880-7C3387CB15D1</gtr:id><gtr:title>Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb96b6aa3fefea76aee96f624a89627"><gtr:id>dfb96b6aa3fefea76aee96f624a89627</gtr:id><gtr:otherNames>Puelles E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_14942_12_12652306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57F05514-9CCB-4F61-8F72-C23FE642E25E</gtr:id><gtr:title>Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb96b6aa3fefea76aee96f624a89627"><gtr:id>dfb96b6aa3fefea76aee96f624a89627</gtr:id><gtr:otherNames>Puelles E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_14942_12_15105370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABA89A75-B1E7-421C-B8C4-9426B302AAE7</gtr:id><gtr:title>Transcriptional repression coordinates the temporal switch from motor to serotonergic neurogenesis.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42df0eb4ddcddd650ff75bdff9d79b7"><gtr:id>f42df0eb4ddcddd650ff75bdff9d79b7</gtr:id><gtr:otherNames>Jacob J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>9BFAFE96655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3991FFF0-00C9-4E9D-B127-D00483F0123D</gtr:id><gtr:title>Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46647b370ab777bcffb2022862715965"><gtr:id>46647b370ab777bcffb2022862715965</gtr:id><gtr:otherNames>Stott SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_14942_22_23637192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0C8EAD1-7EFA-45C1-8CD6-47533256C98B</gtr:id><gtr:title>Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f77e358a2f7e3123c9a08329872d459"><gtr:id>6f77e358a2f7e3123c9a08329872d459</gtr:id><gtr:otherNames>Ye W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_14942_12_11704761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B02DC45C-AB4B-4EC3-A62B-4837C3BEAC02</gtr:id><gtr:title>Foxa1 and Foxa2 positively and negatively regulate Shh signalling to specify ventral midbrain progenitor identity.</gtr:title><gtr:parentPublicationTitle>Mechanisms of development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256fc93fca137f683b17c5087ed86d34"><gtr:id>256fc93fca137f683b17c5087ed86d34</gtr:id><gtr:otherNames>Mavromatakis YE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0925-4773</gtr:issn><gtr:outcomeId>K12EKwfSx4m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9AA6B8F-8F26-451E-BAAF-B3C5268EF77A</gtr:id><gtr:title>Foxa2 regulates alveolarization and goblet cell hyperplasia.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d510a20d4bff4bd2ea3c6cbdea6e89f4"><gtr:id>d510a20d4bff4bd2ea3c6cbdea6e89f4</gtr:id><gtr:otherNames>Wan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_14942_12_14757645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9C8764A-8A7A-4A29-8334-1C2478D049D5</gtr:id><gtr:title>Survival of a Novel Subset of Midbrain Dopaminergic Neurons Projecting to the Lateral Septum Is Dependent on NeuroD Proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f866ece9ee13c82de8b8a205ee4b33b2"><gtr:id>f866ece9ee13c82de8b8a205ee4b33b2</gtr:id><gtr:otherNames>Khan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>5a65c6cc636c45.69003671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26EF9CFC-0A6C-4BC9-997F-200AF91B8FFB</gtr:id><gtr:title>Foxa2 is required for transition to air breathing at birth.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d510a20d4bff4bd2ea3c6cbdea6e89f4"><gtr:id>d510a20d4bff4bd2ea3c6cbdea6e89f4</gtr:id><gtr:otherNames>Wan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14942_12_15452354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE059D70-B3C4-4244-98FC-0C0F992CBEF3</gtr:id><gtr:title>Lmx1a and lmx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06a9acd2f6e7dd907bbe7cea3d2702e5"><gtr:id>06a9acd2f6e7dd907bbe7cea3d2702e5</gtr:id><gtr:otherNames>Yan CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>FEPohGmjYQz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4919526-22C8-4F4F-ADEB-8262B8780BDF</gtr:id><gtr:title>Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e000444aab2b6135afb5083f9700100"><gtr:id>7e000444aab2b6135afb5083f9700100</gtr:id><gtr:otherNames>Metzakopian E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_14942_22_22696295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25021886-2B9B-423F-B1D1-A618176CE8DB</gtr:id><gtr:title>Defects of the body plan of mutant embryos lacking Lim1, Otx2 or Hnf3beta activity.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cafbba2b8ff7efa3f9d0096b61d752e6"><gtr:id>cafbba2b8ff7efa3f9d0096b61d752e6</gtr:id><gtr:otherNames>Kinder SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>pm_14942_12_11291865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4716204F-6C4F-43B6-BB3C-ED35107F1E92</gtr:id><gtr:title>Cell aggregation-induced FGF8 elevation is essential for P19 cell neural differentiation.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55e9c812cfbba94f1e7e00b693cdb8e1"><gtr:id>55e9c812cfbba94f1e7e00b693cdb8e1</gtr:id><gtr:otherNames>Wang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>E020B5F21BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E4C06B1-D454-4EBE-A0D8-E3B7530E98B9</gtr:id><gtr:title>Nodal antagonists in the anterior visceral endoderm prevent the formation of multiple primitive streaks.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca32b76762472986e26587f35328fd74"><gtr:id>ca32b76762472986e26587f35328fd74</gtr:id><gtr:otherNames>Perea-Gomez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_14942_12_12431380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41DF3879-59A9-4ADE-8FF6-A7DEA9DA188C</gtr:id><gtr:title>Cloning of the mouse Sef gene and comparative analysis of its expression with Fgf8 and Spry2 during embryogenesis.</gtr:title><gtr:parentPublicationTitle>Mechanisms of development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8598d94f3340085be4902d35c69c2138"><gtr:id>8598d94f3340085be4902d35c69c2138</gtr:id><gtr:otherNames>Lin W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0925-4773</gtr:issn><gtr:outcomeId>pm_14942_12_11960706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84B8AAA9-CCDB-47ED-B9D7-CE93FAE78488</gtr:id><gtr:title>Maintenance of the specification of the anterior definitive endoderm and forebrain depends on the axial mesendoderm: a study using HNF3beta/Foxa2 conditional mutants.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e74028a4b8e0114329309d48eaba3bad"><gtr:id>e74028a4b8e0114329309d48eaba3bad</gtr:id><gtr:otherNames>Hallonet M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>pm_14942_12_11846474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2F31475-3992-4918-B542-4A1A0C1A59BE</gtr:id><gtr:title>Mash1 is required for generic and subtype differentiation of hypothalamic neuroendocrine cells.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b05484b015c2cfcc021b1d2c92d3d143"><gtr:id>b05484b015c2cfcc021b1d2c92d3d143</gtr:id><gtr:otherNames>McNay DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>15C20094055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7579BC4-7209-4F72-986E-5B9BD57E519F</gtr:id><gtr:title>A gene network establishing polarity in the early mouse embryo.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57f85f6e69f4b446ceeb727eb8b5d685"><gtr:id>57f85f6e69f4b446ceeb727eb8b5d685</gtr:id><gtr:otherNames>Ang SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>pm_14942_12_15271301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EAE8552-D4C1-4F1C-A86D-043DAE26C9A5</gtr:id><gtr:title>Role of the anterior visceral endoderm in restricting posterior signals in the mouse embryo.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca32b76762472986e26587f35328fd74"><gtr:id>ca32b76762472986e26587f35328fd74</gtr:id><gtr:otherNames>Perea-Gomez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>pm_14942_12_11291861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CA1856C-0DA5-43E7-BCB7-E0DFAFA1E4DA</gtr:id><gtr:title>Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb96b6aa3fefea76aee96f624a89627"><gtr:id>dfb96b6aa3fefea76aee96f624a89627</gtr:id><gtr:otherNames>Puelles E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>694F4251C0F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C03A37D6-1C7F-4C6E-BF5E-F27EB4B82371</gtr:id><gtr:title>Otx2 and HNF3beta genetically interact in anterior patterning.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dac6f0a4be826cf8f07eecf5ffaa4a"><gtr:id>05dac6f0a4be826cf8f07eecf5ffaa4a</gtr:id><gtr:otherNames>Jin O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>pm_14942_12_11291866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D14458E7-FACE-4ABA-A15C-C7DCA1C2A350</gtr:id><gtr:title>An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f335383a1d6f5b618e3beda96d80337a"><gtr:id>f335383a1d6f5b618e3beda96d80337a</gtr:id><gtr:otherNames>Saba-El-Leil MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>pm_14942_12_14502223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8475C741-79D5-44C5-8F7D-A2ADD86C139E</gtr:id><gtr:title>Ventral mesencephalon-enriched genes that regulate the development of dopaminergic neurons in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e80f4bbf7a67670259ecb2c4b541aead"><gtr:id>e80f4bbf7a67670259ecb2c4b541aead</gtr:id><gtr:otherNames>Yin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>F9EEA060112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE3210F6-3792-482D-9AD9-1F25F6FFA990</gtr:id><gtr:title>Transcriptional control of midbrain dopaminergic neuron development.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57f85f6e69f4b446ceeb727eb8b5d685"><gtr:id>57f85f6e69f4b446ceeb727eb8b5d685</gtr:id><gtr:otherNames>Ang SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>09CEF76828B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>041DFAF6-B2AE-443C-97A0-8D19CE0F60CE</gtr:id><gtr:title>Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8598d94f3340085be4902d35c69c2138"><gtr:id>8598d94f3340085be4902d35c69c2138</gtr:id><gtr:otherNames>Lin W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>5DEB6647DE5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6FFD2A8-85E1-4D32-B5D4-2BE437D59517</gtr:id><gtr:title>Foxa1 and Foxa2 transcription factors regulate differentiation of midbrain dopaminergic neurons.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57f85f6e69f4b446ceeb727eb8b5d685"><gtr:id>57f85f6e69f4b446ceeb727eb8b5d685</gtr:id><gtr:otherNames>Ang SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>782AC022C35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06C60C9F-5BF5-49A0-90BC-802451543669</gtr:id><gtr:title>Nodal antagonists regulate formation of the anteroposterior axis of the mouse embryo.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5390d23ff61d8caa05bf70a7f3a4192"><gtr:id>f5390d23ff61d8caa05bf70a7f3a4192</gtr:id><gtr:otherNames>Yamamoto M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_14942_12_15004567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9FEB8A7-86BD-492A-9E56-16315874D168</gtr:id><gtr:title>Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c5ab4d96468b3b72124f41c8f43183a"><gtr:id>4c5ab4d96468b3b72124f41c8f43183a</gtr:id><gtr:otherNames>Glaser S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>1CFA6167F17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8046BD25-27F6-4C41-8822-3FBC68C2321A</gtr:id><gtr:title>Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01804f40c337e62aa741d1b3cee4d2f7"><gtr:id>01804f40c337e62aa741d1b3cee4d2f7</gtr:id><gtr:otherNames>Borgkvist A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>7E7FDA600F0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>814C05BF-A3F9-4010-8C09-0AC387395D9D</gtr:id><gtr:title>Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6fee32c2f9a08ce958d79e06b477d58"><gtr:id>b6fee32c2f9a08ce958d79e06b477d58</gtr:id><gtr:otherNames>F?rthauer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_14942_12_11802165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>800FA0F9-7370-4057-AB49-48210155210D</gtr:id><gtr:title>Differential requirements for neurogenin 3 in the development of POMC and NPY neurons in the hypothalamus.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36ac4bda483d4a3cf04e981a093dbc00"><gtr:id>36ac4bda483d4a3cf04e981a093dbc00</gtr:id><gtr:otherNames>Pelling M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>LnZGGoB5mhM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E10DF11-A3D4-418C-B00A-3783FDDBF372</gtr:id><gtr:title>Conditional deletion of neurogenin-3 using Nkx2.1iCre results in a mouse model for the central control of feeding, activity and obesity.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bea88104a4c1f9215c5a24489190f3cd"><gtr:id>bea88104a4c1f9215c5a24489190f3cd</gtr:id><gtr:otherNames>Anthwal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_14942_22_23649822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF8C5FFB-6738-4DC4-9BFD-068EDE644A2E</gtr:id><gtr:title>Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d510a20d4bff4bd2ea3c6cbdea6e89f4"><gtr:id>d510a20d4bff4bd2ea3c6cbdea6e89f4</gtr:id><gtr:otherNames>Wan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>644709E47DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D432EFE9-0297-4971-B527-8AFEC0D9D6AC</gtr:id><gtr:title>Otx2 regulates subtype specification and neurogenesis in the midbrain.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9fd58542acfcfca233358eef85b4eb1"><gtr:id>f9fd58542acfcfca233358eef85b4eb1</gtr:id><gtr:otherNames>Vernay B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>F781C20CB9B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F459AF2-1E6B-456D-8DCA-93550D639BF5</gtr:id><gtr:title>Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f77c8be830211a3930814183eecd688"><gtr:id>1f77c8be830211a3930814183eecd688</gtr:id><gtr:otherNames>Sund NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>pm_14942_12_11445544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B6836BC-110A-452C-9FA0-E14A51A84603</gtr:id><gtr:title>Genome-wide characterisation of Foxa1 binding sites reveals several mechanisms for regulating neuronal differentiation in midbrain dopamine cells.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e000444aab2b6135afb5083f9700100"><gtr:id>7e000444aab2b6135afb5083f9700100</gtr:id><gtr:otherNames>Metzakopian E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>doi_55faa2aa22cc7c05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C026F1E-E754-4D6B-81E5-ADA8FA263B22</gtr:id><gtr:title>Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fea274a638ca37ffef84f98954f7853e"><gtr:id>fea274a638ca37ffef84f98954f7853e</gtr:id><gtr:otherNames>Ferri AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>1850816F212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8932F012-1646-422A-97FA-0A3269907CC5</gtr:id><gtr:title>Genetic control of midbrain dopaminergic neuron development.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce7a4b428579f1310b1d36c318b8fb39"><gtr:id>ce7a4b428579f1310b1d36c318b8fb39</gtr:id><gtr:otherNames>Blaess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-7684</gtr:issn><gtr:outcomeId>585d32415bd434.14055840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E74A2289-0EE5-46AE-B6E2-BAB6953D1451</gtr:id><gtr:title>The allocation and differentiation of mouse primordial germ cells.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5267b87f59a2799defb8a1288b64b0c5"><gtr:id>5267b87f59a2799defb8a1288b64b0c5</gtr:id><gtr:otherNames>Tsang TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>pm_14942_12_11417898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB087A72-DE1D-46D9-9211-4B3BA1C5BD23</gtr:id><gtr:title>Synergistic activity of Sef and Sprouty proteins in regulating the expression of Gbx2 in the mid-hindbrain region.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8598d94f3340085be4902d35c69c2138"><gtr:id>8598d94f3340085be4902d35c69c2138</gtr:id><gtr:otherNames>Lin W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn><gtr:outcomeId>B16BD7DE75C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9E2F117-8040-4FB5-899B-D48D87B2CD32</gtr:id><gtr:title>Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c277abc3bf186c89973797559ed48f8b"><gtr:id>c277abc3bf186c89973797559ed48f8b</gtr:id><gtr:otherNames>Kele J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>7E87E84717D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA9E155D-ABA0-4B0E-946F-8D885685EE23</gtr:id><gtr:title>Erk2 signaling and early embryo stem cell self-renewal.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5133d94a513c25079491a23f0d9e88cf"><gtr:id>5133d94a513c25079491a23f0d9e88cf</gtr:id><gtr:otherNames>Meloche S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_14942_12_14726711</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117570533</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>